NexturnBioscience Co. Ltd (089140) — Free Cash Flow Generation Index
NexturnBioscience Co. Ltd (089140) has a Free Cash Flow Generation Index of 0.94x as of September 2025. Free cash flow of ₩4.23 Billion represents 1% of operating cash flow (₩4.51 Billion). See 089140 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
NexturnBioscience Co. Ltd Free Cash Flow Generation Index (2007–2021)
Historical FCF Generation Index trend for NexturnBioscience Co. Ltd across 12 annual periods. Explore NexturnBioscience Co. Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for NexturnBioscience Co. Ltd (2007–2021)
Year-by-year Free Cash Flow Generation Index for NexturnBioscience Co. Ltd. For the full company profile including market capitalisation, see 089140 company net worth.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.87x | ₩3.18 Billion | ₩3.66 Billion | ₩467.60 Million | ▲ +14.4% |
| 2020 | 0.76x | ₩178.75 Million | ₩235.94 Million | ₩1.21 Billion | ▼ -90.2% |
| 2019 | 7.72x | ₩21.12 Billion | ₩2.74 Billion | ₩18.38 Billion | ▲ +656.5% |
| 2018 | 1.02x | ₩9.83 Billion | ₩9.63 Billion | ₩199.42 Million | ▼ -12.9% |
| 2017 | 1.17x | ₩5.95 Billion | ₩5.08 Billion | ₩870.45 Million | ▲ +11.5% |
| 2016 | 1.05x | ₩18.77 Billion | ₩17.88 Billion | ₩893.46 Million | ▼ -28.7% |
| 2015 | 1.47x | ₩2.82 Billion | ₩1.92 Billion | ₩906.54 Million | ▲ +47.1% |
| 2014 | 1.00x | ₩6.49 Billion | ₩6.48 Billion | ₩8.97 Million | ▼ -83.7% |
| 2010 | 6.15x | ₩1.45 Billion | ₩235.94 Million | ₩1.21 Billion | ▲ +475.7% |
| 2009 | 1.07x | ₩1.07 Billion | ₩998.03 Million | ₩68.11 Million | ▼ -11.6% |
| 2008 | 1.21x | ₩1.14 Billion | ₩945.34 Million | ₩197.16 Million | ▼ -56.1% |
| 2007 | 2.75x | ₩6.23 Billion | ₩2.26 Billion | ₩3.97 Billion | — |